Evidence map›Paper›PMID 17896294›Full record

ReviewOphthalmic epidemiology

Overview of epidemiologic studies of diabetic retinopathy.

Barbara Eden Kobrin Klein

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Ophthalmic epidemiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT02587741. Cited by 323 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
323citing papers in PubMed, 8 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02587741 early_phase1unknown status

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens: a Multicentre Randomized Parallel-group Clinical Trial

Ran2015Enrolled600Registered outcomes6Posted comparisons0ConditionsDiabetic RetinopathyArmsLantus, Metformin, Novomix30
Open the trial in the graph
NCT06146699 unknown statusnot on this map

Status of Diabetic Retinopathy and Its Presentation Patterns in Diabetics at Assiut University Hospital

TypeobservationalSponsorAssiut UniversityRan2023 to 2025Enrolled262ConditionsDiabetic RetinopathyArmsOptical Coherence Tomography (OCT), Fundus fluorescein angiography (FFA)
3 · Its place in the literature

Who cites it

323 citing papers in PubMed, 8 syntheses or guidelines pooled it, 737 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association betweenAging · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Different lasers and techniques for proliferative diabetic retinopathy.The Cochrane database of systematic reviews · 2018
    Pooled it
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

263 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Barbara Eden Kobrin KleinDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53726, USA. kleinb@epi.ophth.wisc.edu

Funding

Epidemiology of Retinopathy and other Complications in Long Term Type 1 DiabetesR01EY016379 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BARBARA EDEN, KLEIN, RONALD · 2005 to 2016
$7.0M
NEI NIH HHS EY016379NEI NIH HHS EY06594
6 · The paper itself

Abstract

Diabetic retinopathy has been an important cause of blindness in young and middle age adults in the United States. Epidemiologic studies have quantitated the risk and have described potentially causal factors associated with many ocular complications of diabetes and other facets of this disease. A review of recent advances in diagnosis, treatment, temporal trends, and health care for diabetic retinopathy was conducted. Since the early 1980's, there have been studies of the variability of diabetic retinopathy in populations around the world and subpopulations in the United States which have demonstrated the high prevalences and incidences of this condition. Observational studies and clinical trials have documented the importance of glycemic and blood pressure control in the development and progression of this disease. There are some differences in the importance of confounders in different populations. Epidemiologic data have helped understand the importance of health care and health education in prevention and treatment of this condition. Observational studies have documented the importance of this disease on quality of life. Although there have been advances in understanding the distribution, causes, and severity of diabetic retinopathy, this is ever changing and requires continued monitoring. This is important because the increasing burden of diabetes will place a greater burden on the population and the medical care systems that will be caring for them.

Indexed as

BlindnessDiabetic RetinopathyEpidemiologic StudiesHumansIncidencePrevalenceQuality of Life

Identifiers

PMID17896294
OpenAlexW2041485080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.